(Q37995506)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

meta-analysis

0 references

title

Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Angelo Restivo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Alan S Rosman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Michele Pisano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Giuseppe R Nigri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Alessandro Fancellu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Marcovalerio Melis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

21 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

Annals of Surgical Oncology

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

2822-2832

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1245/s10434-011-2209-y

26 January 2020

exact match

0 references

cites work

Global cancer statistics in the year 2000.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

21 January 2018

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

A Systematic Overview of Radiation Therapy Effects in Rectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

The value of adjuvant radio(chemo)therapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Preoperative versus postoperative chemoradiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Neoadjuvant therapy for adenocarcinoma of the rectum: tumor response and acute toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

If nothing goes wrong, is everything all right? Interpreting zero numerators

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

The statistical basis of meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Power dressing and meta-analysis: incorporating power analysis into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Preoperative infusional chemoradiation therapy for Stage T3 rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Response to preoperative chemoradiation in stage II and III rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excisi

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Response to neoadjuvant therapy for rectal cancer: influence on long-term results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Biomarkers for response to neoadjuvant chemoradiation for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Alternative clinical end points in rectal cancer--are we getting closer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Management of rectal cancer: short- vs. long-course preoperative radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2209-Y

10.1245/S10434-011-2209-Y

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

26 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22434243%20AND%20SRC:MED&resulttype=core&format=json